SEC Filings for Vertex Pharmaceuticals Incorporated (VRTX)

$ 267.73   -0.45 (-0.17%) Volume: 1.1m 4:00 PM EDT 28-Sep-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)309/21/2020
SC 13DGeneral statement of acquisition of beneficial ownership709/03/2020
4Statement of changes in beneficial ownership of securities108/26/2020
4Statement of changes in beneficial ownership of securities108/10/2020
4Statement of changes in beneficial ownership of securities108/10/2020
4Statement of changes in beneficial ownership of securities108/10/2020
4Statement of changes in beneficial ownership of securities108/10/2020
4Statement of changes in beneficial ownership of securities108/05/2020
4Statement of changes in beneficial ownership of securities108/05/2020
4Statement of changes in beneficial ownership of securities108/05/2020
4Statement of changes in beneficial ownership of securities108/05/2020
4Statement of changes in beneficial ownership of securities108/05/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)4407/31/2020
8-KCurrent report pursuant to Section 13 or 15(d)1707/30/2020
4Statement of changes in beneficial ownership of securities107/17/2020
<<
First
<
Prev
123456789101112131415